nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—Glossitis—Auranofin—psoriatic arthritis	0.0911	0.0911	CcSEcCtD
Mecamylamine—Fibrosis—Methotrexate—psoriatic arthritis	0.0569	0.0569	CcSEcCtD
Mecamylamine—Mydriasis—Prednisolone—psoriatic arthritis	0.0336	0.0336	CcSEcCtD
Mecamylamine—Anorexia—Auranofin—psoriatic arthritis	0.0286	0.0286	CcSEcCtD
Mecamylamine—Decreased appetite—Auranofin—psoriatic arthritis	0.026	0.026	CcSEcCtD
Mecamylamine—Constipation—Auranofin—psoriatic arthritis	0.0256	0.0256	CcSEcCtD
Mecamylamine—Pulmonary oedema—Prednisolone—psoriatic arthritis	0.0238	0.0238	CcSEcCtD
Mecamylamine—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.0219	0.0219	CcSEcCtD
Mecamylamine—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.0219	0.0219	CcSEcCtD
Mecamylamine—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.0199	0.0199	CcSEcCtD
Mecamylamine—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.0199	0.0199	CcSEcCtD
Mecamylamine—Vomiting—Auranofin—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Mecamylamine—Nausea—Auranofin—psoriatic arthritis	0.0178	0.0178	CcSEcCtD
Mecamylamine—Glossitis—Methotrexate—psoriatic arthritis	0.0176	0.0176	CcSEcCtD
Mecamylamine—Pulmonary oedema—Prednisone—psoriatic arthritis	0.0173	0.0173	CcSEcCtD
Mecamylamine—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.0145	0.0145	CcSEcCtD
Mecamylamine—Erectile dysfunction—Prednisone—psoriatic arthritis	0.0112	0.0112	CcSEcCtD
Mecamylamine—Vision blurred—Prednisolone—psoriatic arthritis	0.011	0.011	CcSEcCtD
Mecamylamine—Syncope—Prednisolone—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Mecamylamine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Mecamylamine—Convulsion—Prednisolone—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Mecamylamine—Syncope—Triamcinolone—psoriatic arthritis	0.00965	0.00965	CcSEcCtD
Mecamylamine—Syncope—Methylprednisolone—psoriatic arthritis	0.00963	0.00963	CcSEcCtD
Mecamylamine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00946	0.00946	CcSEcCtD
Mecamylamine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00944	0.00944	CcSEcCtD
Mecamylamine—Shock—Prednisolone—psoriatic arthritis	0.0094	0.0094	CcSEcCtD
Mecamylamine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.0094	0.0094	CcSEcCtD
Mecamylamine—Convulsion—Triamcinolone—psoriatic arthritis	0.00933	0.00933	CcSEcCtD
Mecamylamine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00931	0.00931	CcSEcCtD
Mecamylamine—Syncope—Betamethasone—psoriatic arthritis	0.00876	0.00876	CcSEcCtD
Mecamylamine—Syncope—Dexamethasone—psoriatic arthritis	0.00876	0.00876	CcSEcCtD
Mecamylamine—Shock—Triamcinolone—psoriatic arthritis	0.00864	0.00864	CcSEcCtD
Mecamylamine—Shock—Methylprednisolone—psoriatic arthritis	0.00863	0.00863	CcSEcCtD
Mecamylamine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00859	0.00859	CcSEcCtD
Mecamylamine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00859	0.00859	CcSEcCtD
Mecamylamine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00858	0.00858	CcSEcCtD
Mecamylamine—Convulsion—Dexamethasone—psoriatic arthritis	0.00846	0.00846	CcSEcCtD
Mecamylamine—Convulsion—Betamethasone—psoriatic arthritis	0.00846	0.00846	CcSEcCtD
Mecamylamine—Vision blurred—Prednisone—psoriatic arthritis	0.00802	0.00802	CcSEcCtD
Mecamylamine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00789	0.00789	CcSEcCtD
Mecamylamine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00787	0.00787	CcSEcCtD
Mecamylamine—Shock—Dexamethasone—psoriatic arthritis	0.00784	0.00784	CcSEcCtD
Mecamylamine—Shock—Betamethasone—psoriatic arthritis	0.00784	0.00784	CcSEcCtD
Mecamylamine—Syncope—Prednisone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Mecamylamine—Anorexia—Betamethasone—psoriatic arthritis	0.0076	0.0076	CcSEcCtD
Mecamylamine—Anorexia—Dexamethasone—psoriatic arthritis	0.0076	0.0076	CcSEcCtD
Mecamylamine—Fatigue—Triamcinolone—psoriatic arthritis	0.00758	0.00758	CcSEcCtD
Mecamylamine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00756	0.00756	CcSEcCtD
Mecamylamine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00748	0.00748	CcSEcCtD
Mecamylamine—Convulsion—Prednisone—psoriatic arthritis	0.00737	0.00737	CcSEcCtD
Mecamylamine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00716	0.00716	CcSEcCtD
Mecamylamine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00716	0.00716	CcSEcCtD
Mecamylamine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00693	0.00693	CcSEcCtD
Mecamylamine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00693	0.00693	CcSEcCtD
Mecamylamine—Fatigue—Betamethasone—psoriatic arthritis	0.00687	0.00687	CcSEcCtD
Mecamylamine—Fatigue—Dexamethasone—psoriatic arthritis	0.00687	0.00687	CcSEcCtD
Mecamylamine—Shock—Prednisone—psoriatic arthritis	0.00683	0.00683	CcSEcCtD
Mecamylamine—Vision blurred—Methotrexate—psoriatic arthritis	0.0067	0.0067	CcSEcCtD
Mecamylamine—Anorexia—Prednisone—psoriatic arthritis	0.00662	0.00662	CcSEcCtD
Mecamylamine—Dizziness—Prednisolone—psoriatic arthritis	0.00632	0.00632	CcSEcCtD
Mecamylamine—Asthenia—Triamcinolone—psoriatic arthritis	0.0063	0.0063	CcSEcCtD
Mecamylamine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00629	0.00629	CcSEcCtD
Mecamylamine—Paraesthesia—Prednisone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Mecamylamine—Convulsion—Methotrexate—psoriatic arthritis	0.00616	0.00616	CcSEcCtD
Mecamylamine—Decreased appetite—Prednisone—psoriatic arthritis	0.00604	0.00604	CcSEcCtD
Mecamylamine—Fatigue—Prednisone—psoriatic arthritis	0.00599	0.00599	CcSEcCtD
Mecamylamine—Constipation—Prednisone—psoriatic arthritis	0.00594	0.00594	CcSEcCtD
Mecamylamine—Dizziness—Triamcinolone—psoriatic arthritis	0.00581	0.00581	CcSEcCtD
Mecamylamine—Dizziness—Methylprednisolone—psoriatic arthritis	0.0058	0.0058	CcSEcCtD
Mecamylamine—Asthenia—Betamethasone—psoriatic arthritis	0.00572	0.00572	CcSEcCtD
Mecamylamine—Asthenia—Dexamethasone—psoriatic arthritis	0.00572	0.00572	CcSEcCtD
Mecamylamine—Nausea—Prednisolone—psoriatic arthritis	0.00568	0.00568	CcSEcCtD
Mecamylamine—Vomiting—Triamcinolone—psoriatic arthritis	0.00559	0.00559	CcSEcCtD
Mecamylamine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00557	0.00557	CcSEcCtD
Mecamylamine—Anorexia—Methotrexate—psoriatic arthritis	0.00553	0.00553	CcSEcCtD
Mecamylamine—Dizziness—Betamethasone—psoriatic arthritis	0.00527	0.00527	CcSEcCtD
Mecamylamine—Dizziness—Dexamethasone—psoriatic arthritis	0.00527	0.00527	CcSEcCtD
Mecamylamine—Nausea—Triamcinolone—psoriatic arthritis	0.00522	0.00522	CcSEcCtD
Mecamylamine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00521	0.00521	CcSEcCtD
Mecamylamine—Nausea—Methylprednisolone—psoriatic arthritis	0.00521	0.00521	CcSEcCtD
Mecamylamine—Vomiting—Betamethasone—psoriatic arthritis	0.00507	0.00507	CcSEcCtD
Mecamylamine—Vomiting—Dexamethasone—psoriatic arthritis	0.00507	0.00507	CcSEcCtD
Mecamylamine—Decreased appetite—Methotrexate—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Mecamylamine—Fatigue—Methotrexate—psoriatic arthritis	0.005	0.005	CcSEcCtD
Mecamylamine—Asthenia—Prednisone—psoriatic arthritis	0.00498	0.00498	CcSEcCtD
Mecamylamine—Nausea—Betamethasone—psoriatic arthritis	0.00474	0.00474	CcSEcCtD
Mecamylamine—Nausea—Dexamethasone—psoriatic arthritis	0.00474	0.00474	CcSEcCtD
Mecamylamine—Dizziness—Prednisone—psoriatic arthritis	0.00459	0.00459	CcSEcCtD
Mecamylamine—Vomiting—Prednisone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Mecamylamine—Asthenia—Methotrexate—psoriatic arthritis	0.00416	0.00416	CcSEcCtD
Mecamylamine—Nausea—Prednisone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Mecamylamine—Dizziness—Methotrexate—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Mecamylamine—Vomiting—Methotrexate—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Mecamylamine—Nausea—Methotrexate—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
